Navigation Links
Halo Therapeutics Raises $1.1 Million to Expedite Phase 2 Study of HT-100
Date:5/22/2012

very Foundation and father of Nash, age 12. "This level of unification and engagement across the patient advocacy community for an early-stage drug candidate is extremely rare, and we are grateful for the support and vision of our funding partners."

Added Benjamin Seckler, M.D., president of Charley's Fund and father of Charley, age 11: "We have the ultimate drive to get this done quickly: Our children's lives are at stake. We do not have the option of accepting the pace of typical drug development efforts. We thank our foundation partners and value their role in helping us further the development of HT-100 as rapidly as possible."

The foundations providing support include:

Action Duchenne
Coalition Duchenne
Cure Duchenne
Duchenne Now
Duchenne Research Fund
Hope for Gus
Hope for Javier
Jain Foundation
Michael's Cause
Parent Project Muscular Dystrophy
Ryan's Quest
Zubin's Wish

About Duchenne Muscular DystrophyDuchenne muscular dystrophy is caused by a mutation in the dystrophin gene, resulting in progressive muscle weakness. The disease manifests itself first in weakened skeletal muscles and eventually results in cardiac and pulmonary impairment. Corticosteroids are the current standard of care treatment for DMD.  While this treatment delays disease progression by several years, their prolonged use is typically associated with side effects and the treatment does not alter the ultimate outcome of the disease.

About Halo TherapeuticsBased in Newton, Mass., Halo Therapeutics, LLC, is a clinical-stage biopharmaceutical firm focused on developing innovative therapies for rare fibrotic diseases like Duchenne muscular dystrophy. Founded through a collaboration between patient advocacy organizations and industry veterans, the company is partnering with the clinical community and patients to transform therapeutic options and, by extension, lives. For more information, please visit

SOURCE Halo Therapeutics, LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
3. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
4. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
5. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
6. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
7. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
8. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
9. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
10. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
11. Cell Therapeutics, Inc. (CTI) Sponsors Panel Discussion on Women and Lung Cancer on Capitol Hill
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... -- Strategic Health Services, Inc. (SHS), a leading provider of ... agreement with QualCare, Inc., a leading provider of health plans ... marketplace.  This agreement will further QualCare,s population health management ... brings to its clients in New Jersey ... QualCare plans cover more than 800,000 member lives, with ...
(Date:12/17/2014)... December 17, 2014 , ... than a hub of information concerning the biopharmaceutical Group,s national ... A further addition to the recently launched institutional website that ... now been enriched by a new chapter in the fascinating ... A richly detailed and panoramic hub on the world of ...
(Date:12/17/2014)... RALEIGH, N.C. , Dec. 17, 2014 ... and Integrated Clinical Trial Services, LLC (ICTS), two ... clinical trials announce that they have formed a ... (i-CTMS). i-CTMS will provide a broad range of ... and medical device companies. i-CTMS will ...
Breaking Medicine Technology:Strategic Health Services to collaborate with QualCare on Population Health and Wellness Technology for QualCare Members 2Strategic Health Services to collaborate with QualCare on Population Health and Wellness Technology for QualCare Members 3Dompé Offers a New "Window" on the World of Scientific Research, with the http://www.dompetrials.com Website, Dedicated to Clinical Trials 2Dompé Offers a New "Window" on the World of Scientific Research, with the http://www.dompetrials.com Website, Dedicated to Clinical Trials 3Integrated Clinical Trial Services and Clinical Trial Marketing Communications Form Joint Venture 2Integrated Clinical Trial Services and Clinical Trial Marketing Communications Form Joint Venture 3
... IDM Pharma, Inc.,(Nasdaq: IDMI ) today ... for Medicinal Products for Human Use (CHMP) and ... 25th, following the,CHMP,s September meeting where CHMP considered ... for the,treatment of patients with non-metastatic, resectable osteosarcoma, ...
... Preventing Possibly Life-Threatening,Condition During Air Travel, ALEXANDRIA, ... (APTA) supports the recent "Call to Action" by,Acting ... reduce the number of,cases of deep vein thrombosis ... According to Susan Scherer, PT, PhD, associate professor ...
Cached Medicine Technology:IDM Pharma Provides Update on Mifamurtide (L-MTP-PE) Regulatory Status Following September Meeting of European Committee for Medicinal Products for Human Use (CHMP) 2IDM Pharma Provides Update on Mifamurtide (L-MTP-PE) Regulatory Status Following September Meeting of European Committee for Medicinal Products for Human Use (CHMP) 3IDM Pharma Provides Update on Mifamurtide (L-MTP-PE) Regulatory Status Following September Meeting of European Committee for Medicinal Products for Human Use (CHMP) 4IDM Pharma Provides Update on Mifamurtide (L-MTP-PE) Regulatory Status Following September Meeting of European Committee for Medicinal Products for Human Use (CHMP) 5APTA Supports Surgeon General's 'Call to Action' to Prevent Deep Vein Thrombosis and Pulmonary Embolism 2APTA Supports Surgeon General's 'Call to Action' to Prevent Deep Vein Thrombosis and Pulmonary Embolism 3
(Date:12/15/2014)... CITY, NV (PRWEB) December 15, 2014 ... powerhouse company, JM Ocean Avenue. JM Ocean Avenue ... of the Veretekk online automated marketing system. JM ... the June 2014 merger of Ocean Avenue and JM ... more than $2 Billion per year company. , “After ...
(Date:12/15/2014)... 15, 2014 OutMarket , a ... “ Social Media Cheat Sheets ,” a guide that ... drives results on the top ten social media networks. ... helps drive awareness, engagement, and customer service. It can ... make an impact on new networks and weather constantly ...
(Date:12/15/2014)... 2014 The increase in prevalence of disabling ... main factors which is contributing to the growth in the ... and treatment of hearing loss and balance disorders are known ... - microphone, speaker and amplifier. The global market is expected ... during the period from 2014 to 2019. Some of the ...
(Date:12/15/2014)... 2014 At the leading, long-established event ... and Focus Autism will welcome scientists ... on the effects of toxins to children’s health, as ... , Luminaries such as Dr. Lucija Tomljenovic and ... esteemed, credentialed colleagues of the United States to present ...
(Date:12/15/2014)... Metal drilling machines have a ... score indicates that neither buyers nor suppliers have a ... been raising the price of metal drilling machines during ... demand,” according to IBISWorld business research analyst, Jeffrey Cohen. ... the past three years, high price driver volatility has ...
Breaking Medicine News(10 mins):Health News:JM Ocean Avenue secures the strategic advantages of Veretekk 2Health News:JM Ocean Avenue secures the strategic advantages of Veretekk 3Health News:JM Ocean Avenue secures the strategic advantages of Veretekk 4Health News:OutMarket Releases Cheat Sheets for Social Media Marketing 2Health News:OutMarket Releases Cheat Sheets for Social Media Marketing 3Health News:Audiological Devices Market 2019 Demand for Esthetic Hearing Aids Drives the Growth, Says a Report at ReportsnReports.com 2Health News:Audiological Devices Market 2019 Demand for Esthetic Hearing Aids Drives the Growth, Says a Report at ReportsnReports.com 3Health News:Audiological Devices Market 2019 Demand for Esthetic Hearing Aids Drives the Growth, Says a Report at ReportsnReports.com 4Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 3Health News:Metal Drilling Machines Procurement Category Market Research Report Now Available from IBISWorld 2Health News:Metal Drilling Machines Procurement Category Market Research Report Now Available from IBISWorld 3
... ... Asks What’s Next for Doctors under New Healthcare Reform Bill, , ... Dallas, TX (Vocus) April 19, 2010 – The recent ... ’ ( Brown Books ) addresses how the health care system has been hostage for ...
... ... ... 18, 2010 -- This weekend, more than 30,000 attendees at the International Cannabis & ... to the nation’s first retail branded, complete medical marijuana product line. , , ,YAK ...
... to help with care, researchers say , SUNDAY, April 18 ... ill older people in the United States live alone, a ... to take care of their parents and relatives, a new ... significantly help many patients with chronic illness manage their health ...
... ... North East Alabama, has successfully completed deployment of CellTrak workflow automation and visit compliance ... HR payroll. , ... Schaumburg, IL (PRWEB) April 18, 2010 -- ABC Hospice, Inc, a premier hospice provider ...
... ... Washington, hits the big time , ... Oak Harbor, WA (PRWEB) April 19, 2010 -- In the highly-competitive natural skincare industry, ... Tacia, Oak Harbor resident and owner of Bella Vé Natural Skin Care, has recently launched ...
... faster times as the goal, while females hope to ... -- Women run marathons to feel good while men run ... suggests. , The research included 507 female and 399 male ... questionnaire designed to reveal the participants, motivation for taking part ...
Cached Medicine News:Health News:Recent Book Moves Beyond Defensive Medicine, Tackles Entitlement Reform 2Health News:Recent Book Moves Beyond Defensive Medicine, Tackles Entitlement Reform 3Health News:First Retail Branded Edible Medical Marijuana Product Line Introduced at San Francisco Trade Show 2Health News:First Retail Branded Edible Medical Marijuana Product Line Introduced at San Francisco Trade Show 3Health News:First Retail Branded Edible Medical Marijuana Product Line Introduced at San Francisco Trade Show 4Health News:1 in 4 Chronically Ill Elderly Lives Alone 2Health News:CellTrak Increases Employee Productivity and Efficiencies at ABC Hospice, Inc. 2Health News:CellTrak Increases Employee Productivity and Efficiencies at ABC Hospice, Inc. 3Health News:Hollywood Eco-Celebrity Rachelle Carson-Begley Gives Skincare Company Bella V Rave Reviews 2Health News:Hollywood Eco-Celebrity Rachelle Carson-Begley Gives Skincare Company Bella V Rave Reviews 3Health News:Hollywood Eco-Celebrity Rachelle Carson-Begley Gives Skincare Company Bella V Rave Reviews 4Health News:Are Male Marathoners More Competitive Than Women? 2
...
...
Ascent Primary Knee System with cruciate retaining, posterior stabilized and constrained components...
Ascent Primary Knee System with cruciate retaining, posterior stabilized and constrained components...
Medicine Products: